Fracture risk possible from heartburn drugs
The Food and Drug Administration warned that the risk of getting a spine, hip and wrist fracture might be there by taking some heartburn medications with long-term use.
Gastroesophageal reflux disease are treated by proton pump inhibitors. These PPIs are also used for the treatment of small intestine and stomach and ulcers and inflammation of the esophagus, along with frequent heartburn.
On Tuesday in a statement the FDA said that the product labeling will be changed to describe the possible increased risk.
Dr Joyce Korvick, deputy director for safety in FDA's Division of Gastroenterology Products said, "Epidemiology studies suggest a possible increased risk of bone fractures with the use of proton pump inhibitors for one year or longer, or at high doses."
The FDA's warning about revised labeling is prompted by the various studies that reported an increased risk of spine, wrist, and hip fractures in people using proton pump inhibitors.
New Zealand News
- Tesla offering new discounts & perks in China amid negative press
- Electric Vehicle Council slams Victoria Government for proposed punitive mileage tax on electric cars
- Chinese EV brand Ora unveils VW Beetle-inspired electric car Punk Cat
- Swapping personal car for e-bicycle saved over $50,000 in just 7 years: San Francisco woman
- Hyundai Motor Corp to create ultra-fast EV charging network E-pit in Korea
- Tesla pockets roughly $101 million in profit from sale of some of its bitcoins
- Norway’s ICE car sales decline as buyers making shift to EVs
- Pursang launches Retro-inspired E-Track Motorcycle for Euro 14,449 in Netherlands
- ElectReon successfully tests dynamic wireless EV charging system on public road in Sweden
- Volvo to design special Gothenburg Green City Zone for autonomous & related technologies